GlassScriptPhysician profile
Sara M Corr
NPI 1942435680
$1,648.05
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $32.79 · 2021: $22.74 · 2022: $31.04.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $159.68 | 2019 | |
| Novo Nordisk INC | $136.78 | 2019 | |
| Lilly USA, LLC | $136.60 | 2019 | |
| Glaxosmithkline, LLC. | $126.81 | 2019 | |
| Janssen Pharmaceuticals, INC | $125.33 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $95.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.49 | 2019 | |
| Abbvie INC. | $92.55 | 2019-2022 | |
| Amgen INC. | $85.29 | 2019 | |
| Astellas Pharma US INC | $77.31 | 2019 | |
| Allergan, INC. | $69.42 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $65.87 | 2019 | |
| Pfizer INC. | $39.28 | 2019 | |
| Amarin Pharma, INC. | $38.00 | 2019 | |
| Horizon Therapeutics Plc | $34.78 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $27.50 | 2019 | |
| Hikma Pharmaceuticals USA | $23.17 | 2019 | |
| Genentech USA, INC. | $20.01 | 2019 | |
| Shire North American Group INC | $18.20 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $16.88 | 2019 | |
| Endo Pharmaceuticals INC. | $16.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $16.29 | 2019 | |
| Therapeuticsmd, INC. | $16.22 | 2019 | |
| Avanir Pharmaceuticals, INC. | $15.65 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.48 | 2019 | |
| Dynavax Technologies Corporation | $13.36 | 2019 | |
| Aytu Biopharma, INC. | $13.04 | 2019 | |
| Merck Sharp & Dohme LLC | $12.95 | 2019 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.70 | 2019 | |
| Ibsa Pharma INC. | $11.69 | 2019 | |
| Daiichi Sankyo INC. | $11.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Corr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.